Recent CNSP News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2026 12:35:29 PM
- CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline • ACCESS Newswire • 03/11/2026 12:35:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 10:02:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 10:00:26 PM
- CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team • ACCESS Newswire • 03/02/2026 01:25:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/27/2026 10:22:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 01:35:58 PM
- CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation • ACCESS Newswire • 02/17/2026 01:25:00 PM
- CNS Pharmaceuticals Issues Letter to Shareholders • ACCESS Newswire • 01/27/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 10:01:02 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 10:00:04 PM
- CNS Pharmaceuticals Shares Dip After CEO Departure Announcement • IH Market News • 12/17/2025 03:12:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2025 01:43:58 PM
- CNS Pharmaceuticals Announces CEO Transition • ACCESS Newswire • 12/17/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2025 10:19:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 10:00:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 10:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 10:00:02 PM
- CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update • ACCESS Newswire • 11/17/2025 01:35:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 10:10:42 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/12/2025 10:00:13 PM
- CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting • ACCESS Newswire • 11/10/2025 01:45:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/04/2025 05:19:18 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 10/28/2025 01:28:04 AM
